Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals: Responses from a survey of National Control Laboratories and National Regulatory Authorities.

Lilley, Elliot; Bruysters, Martijn; Das, Pradip; Gill, Simeon; Isbrucker, Richard; Jones, David; Holmes, Anthony

Lilley, Elliot; Bruysters, Martijn; Das, Pradip; Gill, Simeon; Isbrucker, Richard; Jones, David; Holmes, Anthony.

Afiliación

Lilley E; NC3Rs, London, UK. Electronic address: elliot.lilley@nc3rs.org.uk.
Bruysters M; National Institute of Public Health and the Environment, Bilthoven, the Netherlands.
Das P; Biological E Limited, Hyderabad, India.
Gill S; AstraZeneca, Cambridge, UK.
Isbrucker R; World Health Organisation, Geneva, Switzerland.
Jones D; Consultant - formally MHRA, UK.
Holmes A; NC3Rs, London, UK.

Biologicals ; 84: 101721, 2023 Nov.

Article en En | MEDLINE | ID: mdl-37922625

Asunto(s)

Laboratorios; Vacunas; Humanos; Animales; Factores Biológicos; Control de Calidad; Encuestas y Cuestionarios

Palabras clave

3Rs; Batch release testing; Biological therapeutics; NC3Rs; National Control Laboratories; National Regulatory Authorities; Non-animal testing strategies; Quality control; Survey; Vaccine manufacturers; Vaccines; WHO

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas / Laboratorios Límite: Animals / Humans Idioma: En Revista: Biologicals Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google